Face Values Spf 15 Facial Moisturizer

Octinoxate, Octisalate, Oxybenzone


Harmon Stores, Inc.
Human Otc Drug
NDC 63940-073
Face Values Spf 15 Facial Moisturizer also known as Octinoxate, Octisalate, Oxybenzone is a human otc drug labeled by 'Harmon Stores, Inc.'. National Drug Code (NDC) number for Face Values Spf 15 Facial Moisturizer is 63940-073. This drug is available in dosage form of Lotion. The names of the active, medicinal ingredients in Face Values Spf 15 Facial Moisturizer drug includes Octinoxate - 30 mg/mL Octisalate - 50 mg/mL Oxybenzone - 30 mg/mL . The currest status of Face Values Spf 15 Facial Moisturizer drug is Active.

Drug Information:

Drug NDC: 63940-073
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Face Values Spf 15 Facial Moisturizer
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Octinoxate, Octisalate, Oxybenzone
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Harmon Stores, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Lotion
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:OCTINOXATE - 30 mg/mL
OCTISALATE - 50 mg/mL
OXYBENZONE - 30 mg/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 08 Mar, 2013
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 15 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part352
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:HARMON STORES, INC.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0071661426508
UPC stands for Universal Product Code.
UNII:4Y5P7MUD51
4X49Y0596W
95OOS7VE0Y
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
63940-073-051 BOTTLE, PUMP in 1 CARTON (63940-073-05) / 118 mL in 1 BOTTLE, PUMP (63940-073-04)08 Mar, 2013N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose sunscreen

Product Elements:

Face values spf 15 facial moisturizer octinoxate, octisalate, oxybenzone water octyldodecyl neopentanoate glycerin cetostearyl alcohol polysorbate 60 glyceryl monostearate peg-100 stearate dimethicone trolamine diazolidinyl urea methylparaben ethylparaben propylparaben carbomer interpolymer type a (allyl sucrose crosslinked) octinoxate octinoxate octisalate octisalate oxybenzone oxybenzone

Indications and Usage:

Uses helps prevent sunburn

Warnings:

Warnings skin cancer/skin aging alert : spending time in the sun increases your risk of skin cancer and early skin aging. this product has been shown only to prevent sunburn, not skin cancer or early skin aging. for external use only

Do Not Use:

Warnings skin cancer/skin aging alert : spending time in the sun increases your risk of skin cancer and early skin aging. this product has been shown only to prevent sunburn, not skin cancer or early skin aging. for external use only

When Using:

When using this product • keep out of eyes. rinse with water to remove.

Dosage and Administration:

Directions apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating children under 6 months of age: ask a doctor

Package Label Principal Display Panel:

Face values oil-free spf 15 moisturizing lotion 4 fl oz (118ml) ndc 63940-069-04 face values oil-free spf 15 moisturizing lotion blister pack ndc 63940-069-05 labelfront labelback blister pack

Further Questions:

Questions or comments? call toll free 1-800-527-7731


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.